Gabelli Funds LLC Has $13.33 Million Position in Masimo Co. (MASI)

Gabelli Funds LLC decreased its position in Masimo Co. (NASDAQ:MASI) by 2.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 107,000 shares of the medical equipment provider’s stock after selling 3,000 shares during the quarter. Gabelli Funds LLC owned 0.21% of Masimo worth $13,326,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. United Services Automobile Association increased its stake in Masimo by 0.7% in the second quarter. United Services Automobile Association now owns 71,510 shares of the medical equipment provider’s stock valued at $6,983,000 after purchasing an additional 485 shares during the last quarter. US Bancorp DE increased its stake in Masimo by 36.9% in the second quarter. US Bancorp DE now owns 1,980 shares of the medical equipment provider’s stock valued at $193,000 after purchasing an additional 534 shares during the last quarter. Oregon Public Employees Retirement Fund increased its stake in Masimo by 3.0% in the second quarter. Oregon Public Employees Retirement Fund now owns 18,628 shares of the medical equipment provider’s stock valued at $1,819,000 after purchasing an additional 535 shares during the last quarter. Security Asset Management increased its stake in Masimo by 4.4% in the third quarter. Security Asset Management now owns 12,834 shares of the medical equipment provider’s stock valued at $1,598,000 after purchasing an additional 539 shares during the last quarter. Finally, Janney Capital Management LLC increased its stake in Masimo by 11.2% in the second quarter. Janney Capital Management LLC now owns 6,115 shares of the medical equipment provider’s stock valued at $597,000 after purchasing an additional 614 shares during the last quarter. 83.22% of the stock is currently owned by hedge funds and other institutional investors.

Shares of MASI opened at $115.49 on Friday. The company has a market cap of $6.23 billion, a PE ratio of 40.39, a price-to-earnings-growth ratio of 2.76 and a beta of 1.11. Masimo Co. has a 12-month low of $80.69 and a 12-month high of $126.89.

Masimo (NASDAQ:MASI) last announced its earnings results on Wednesday, October 31st. The medical equipment provider reported $0.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.02. The business had revenue of $210.58 million for the quarter, compared to analyst estimates of $207.62 million. Masimo had a net margin of 17.08% and a return on equity of 20.29%. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period last year, the firm posted $0.56 earnings per share. As a group, research analysts predict that Masimo Co. will post 2.92 EPS for the current year.

Several equities analysts have commented on the stock. Piper Jaffray Companies increased their price target on shares of Masimo to $120.00 and gave the company a “neutral” rating in a research note on Thursday, November 1st. BidaskClub lowered shares of Masimo from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 3rd. Stifel Nicolaus increased their price target on shares of Masimo from $108.00 to $112.00 and gave the company a “buy” rating in a research note on Thursday, August 2nd. Zacks Investment Research lowered shares of Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. Finally, Needham & Company LLC assumed coverage on shares of Masimo in a research note on Friday, September 14th. They issued a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $114.40.

In other news, Director Sanford Fitch sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $113.14, for a total transaction of $226,280.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Ramshorst David J. Van sold 2,675 shares of the firm’s stock in a transaction that occurred on Monday, September 24th. The stock was sold at an average price of $122.87, for a total transaction of $328,677.25. Following the transaction, the insider now owns 2,325 shares in the company, valued at $285,672.75. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 666,033 shares of company stock worth $79,900,568. Insiders own 12.60% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Gabelli Funds LLC Has $13.33 Million Position in Masimo Co. (MASI)” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/11/10/gabelli-funds-llc-has-13-33-million-position-in-masimo-co-masi.html.

Masimo Company Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Further Reading: Swap

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply